P. Aukrust et al., ELEVATED PLASMA-LEVELS OF REDUCED HOMOCYSTEINE IN COMMON VARIABLE IMMUNODEFICIENCY - A MARKER OF ENHANCED OXIDATIVE STRESS, European journal of clinical investigation, 27(9), 1997, pp. 723-730
Citations number
31
Categorie Soggetti
Medicine, Research & Experimental","Medicine, General & Internal
Based on previous studies from our group, we hypothesized that enhance
d oxidative stress in association with a persistent immune activation
may be important in both the immunopathogenesis and certain clinical m
anifestations in a subgroup of patients with common variable immunodef
iciency (CVI). To explore this hypothesis further, we examined plasma
levels of Lipid peroxidation, antioxidant vitamins and redox status of
various thiol species in 20 CVI patients and 16 healthy control subje
cts. We found significantly higher malondialdehyde (MDA) levels in pla
sma from CVI patients than in healthy control subjects. Furthermore, i
n a subgroup of CVI patients characterized by persistent immune activa
tion in vivo (CVIHyper), we found significantly decreased levels of vi
tamin E and beta-carotene. In the CVI patients, there was a significan
t inverse correlation between MDA levels and levels of vitamin E and b
eta-carotene. Finally, we found a marked elevation in plasma levels of
reduced homocysteine in the CVI group, but no corresponding rise in p
lasma levels of total homocysteine. In the CVI group, the high plasma
levels of reduced homocysteine were significantly correlated with enha
nced Lipid peroxidation and low levels of vitamin E. The results of th
e present study further support a role for enhanced oxidative stress i
n the immunopathogenesis of CVI. Furthermore, our finding of markedly
elevated plasma levels of reduced homocysteine in CVI patients without
simultaneous elevation of other homocysteine species suggests that th
is disturbance in homocysteine metabolism may be related to enhanced o
xidative stress.